Ads
related to: pfizer- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Schedule A Vaccine
Search results
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 4 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via Yahoo News· 5 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 4 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoPfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported ...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 16 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 15 hours agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...